These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 31639727

  • 1. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays.
    Wang D, Caddell B, Nolte FS, Babic N.
    J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the Siemens Atellica BRAHMS and the Abbott Architect BRAHMS Procalcitonin Assays.
    Walker C, Shuster A, Weber C, Gebhardt K, Scheidegger M, Swartzwelder J, Williams J, Li J.
    Ann Clin Lab Sci; 2021 Mar; 51(2):241-244. PubMed ID: 33941564
    [Abstract] [Full Text] [Related]

  • 3. Validation of the Procalcitonin Assay on the Abbott Architect i1000.
    Pagaduan JV, Tam E, Devaraj S.
    J Appl Lab Med; 2019 May; 3(6):936-942. PubMed ID: 31639685
    [Abstract] [Full Text] [Related]

  • 4. How to: implement procalcitonin testing in my practice.
    Neeser O, Branche A, Mueller B, Schuetz P.
    Clin Microbiol Infect; 2019 Oct; 25(10):1226-1230. PubMed ID: 30616016
    [Abstract] [Full Text] [Related]

  • 5. Analytical evaluation of the novel Lumipulse G BRAHMS procalcitonin immunoassay.
    Ruzzenente O, Salvagno GL, Gelati M, Lippi G.
    Pract Lab Med; 2016 Dec 01; 6():8-13. PubMed ID: 28856208
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of procalcitonin immunoassay concordance near clinical decision points.
    Chambliss AB, Hayden J, Colby JM.
    Clin Chem Lab Med; 2019 Aug 27; 57(9):1414-1421. PubMed ID: 30763263
    [Abstract] [Full Text] [Related]

  • 7. As a Novel Procalcitonin Assay is Architect B∙R∙A∙H∙M∙S PCT; Comparison of Two Commercial Systems.
    Aydemir Ö, Karakeçe E, Köroğlu M, Aydemir Y, Terzi HA, Erkorkmaz Ü, Altindiş M.
    Clin Lab; 2019 Apr 01; 65(4):. PubMed ID: 30969065
    [Abstract] [Full Text] [Related]

  • 8. [Evaluation of procalcitonin assay on the Abbott Architect i2000 SR® analyzer].
    El Mouatani A, Rotaru I, Beaudeux JL, Hennequin C.
    Ann Biol Clin (Paris); 2018 Jun 01; 76(3):308-312. PubMed ID: 29622524
    [Abstract] [Full Text] [Related]

  • 9. Multicenter comparison of automated procalcitonin immunoassays.
    Dipalo M, Guido L, Micca G, Pittalis S, Locatelli M, Motta A, Bianchi V, Callegari T, Aloe R, Da Rin G, Lippi G.
    Pract Lab Med; 2015 Aug 01; 2():22-28. PubMed ID: 28932801
    [Abstract] [Full Text] [Related]

  • 10. Two-center comparison of 10 fully-automated commercial procalcitonin (PCT) immunoassays.
    Lippi G, Salvagno GL, Gelati M, Pucci M, Lo Cascio C, Demonte D, Faggian D, Plebani M.
    Clin Chem Lab Med; 2019 Dec 18; 58(1):77-84. PubMed ID: 31539351
    [Abstract] [Full Text] [Related]

  • 11. Embracing Procalcitonin for Antimicrobial Stewardship.
    Chambliss AB.
    J Appl Lab Med; 2019 Jan 18; 3(4):712-715. PubMed ID: 31639737
    [No Abstract] [Full Text] [Related]

  • 12. Evaluation of a fully automated procalcitonin chemiluminescence immunoassay.
    Hubl W, Krassler J, Zingler C, Pertschy A, Hentschel J, Gerhards-Reich C, Mack M, Demant T.
    Clin Lab; 2003 Jan 18; 49(7-8):319-27. PubMed ID: 12908732
    [Abstract] [Full Text] [Related]

  • 13. Host response biomarkers in sepsis: the role of procalcitonin.
    Vincent JL, Van Nuffelen M, Lelubre C.
    Methods Mol Biol; 2015 Jan 18; 1237():213-24. PubMed ID: 25319789
    [Abstract] [Full Text] [Related]

  • 14. The use of procalcitonin for the management of sepsis in Internal Medicine wards: current evidence.
    Tosoni A, Paratore M, Piscitelli P, Addolorato G, De Cosmo S, Mirijello A, Internal Medicine Sepsis Study Group.
    Panminerva Med; 2020 Mar 18; 62(1):54-62. PubMed ID: 31729202
    [Abstract] [Full Text] [Related]

  • 15. Development of a novel chemiluminescence immunoassay for the detection of procalcitonin.
    Wang G, Wan Y, Lin G, Li Z, Dong Z, Liu T.
    J Immunol Methods; 2020 Mar 18; 484-485():112829. PubMed ID: 32673618
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Development of magnetic particle-based chemiluminescence immunoassay for measurement of human procalcitonin in serum.
    Liao M, Zheng J, Xu Y, Qiu Y, Xia C, Zhong Z, Liu L, Liu H, Liu R, Liang S.
    J Immunol Methods; 2021 Jan 18; 488():112913. PubMed ID: 33189726
    [Abstract] [Full Text] [Related]

  • 18. Analytical evaluation of the novel VITROS BRAHMS procalcitonin immunoassay.
    Dupuy AM, Bargnoux AS, Montagnon V, Kuster N, Badiou S, Cristol JP.
    Scand J Clin Lab Invest; 2020 Nov 18; 80(7):541-545. PubMed ID: 33124916
    [Abstract] [Full Text] [Related]

  • 19. How to best use procalcitonin to diagnose infections and manage antibiotic treatment.
    Schuetz P.
    Clin Chem Lab Med; 2023 Apr 25; 61(5):822-828. PubMed ID: 36317790
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.